<DOC>
	<DOC>NCT00314860</DOC>
	<brief_summary>Restless Legs Syndrome (RLS) study in adults comparing immediate release ropinirole with extended release ropinirole over 12 weeks</brief_summary>
	<brief_title>RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>Diagnosis of primary RLS according to RLS Diagnostic Clinical Interview and International Restless Legs Syndrome Study Group Diagnostic Criteria. Disturbed sleep, with both evening (between 5:00 pm and 8:00 pm) and night time (between 8:00 pm and 8:00 am) symptoms requiring treatment. Exclusion criteria: Signs of secondary RLS. Primary sleep disorder or movement disorder other than RLS. Unstable medical conditions. Inability to tolerate dopamine agonists or dopamine antagonists. Unwilling to discontinue any medications currently being taken to treat RLS symptoms.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Restless Legs Syndrome</keyword>
</DOC>